WELL Innovation Feature encourages organizations to address greenhouse gas emissions as part of broader focus on health and well-being
NEW YORK, September 22, 2021 /3BL Media/ - The International WELL Building Institute (IWBI) has added a new innovation feature to the WELL Building Standard (WELL) that rewards climate leadership with the goal of accelerating emission reductions in the face of ever-increasing public health impacts of climate change.
When it comes to cancer, knowledge is power—and sequencing brought answers for one California couple
“Growing up, I had a fear of being broadsided. The idea of an out-of-nowhere collision that might kill or maim me was terrifying. I grew out of this fear and while I’ve never been in that kind of accident, I have been repeatedly broadsided by cancer for the past 11 years.”
Last year, our employee-led People & Business Resource Groups identified impactful organizations fighting disparities and discrimination. When U.S. and Puerto Rico-based employees donate to these selected groups, the Bristol Myers Squibb Foundation double-matches their gifts. Learn more about this special Employee Giving program.
More than 150 colleagues from 14 EU countries just finished cycling 3,000 km in our Country 2 Country 4 Cancer (C2C4C) event to raise awareness and much-needed donations for cancer research. It’s more than a bike ride — together, as one global BMS family, it’s part of our long-standing commitment to cancer research and our patients.
Myelodysplastic syndromes, or MDS, is a rare type of blood cancer primarily affecting people over the age of 65. In fact, it’s such a rare and largely unknown illness that most people living with MDS don’t know anyone else who suffers from it. For Tracey Iraca, Executive Director of the MDS Foundation, a global advocacy organization aimed at providing support and raising awareness of the illness, the most rewarding part of her job is bringing people with MDS together and watching them connect over their shared experiences.
Genomics-Focused Fund Will Support Start-Ups in Healthcare Innovation
San Francisco, September 29, 2021 /3BL Media/ – Illumina Ventures, an independently-managed, healthcare-focused venture firm, announced today the closing of its second investment fund with total commitments of $325 million, bringing its total capital under management to $560 million. The latest fund is anchored by Illumina, Inc. (Nasdaq: ILMN), with the majority of the total committed capital from other strategic and financial investors, including the Ireland Strategic Investment Fund (ISIF).
At the height of the COVID-19 pandemic, Ruth Clements worked 18 hours a day for Quest Diagnostics as the leader of a $100 million initiative, Quest for Health Equity, to close healthcare gaps exposed by the virus.
“I know everything that you could think of when it comes to COVID-19,” says Clements, who also serves as GM of the company’s infectious disease and immunology section.
A decade of strategic partnerships, private sector innovation and data-driven impact to help create a world where no woman has to die while giving life
Giving birth can be one of the most beautiful and joyous experiences in a woman’s life, but for many — too many — it can be a scary and tragic event.
Maternal mortality worldwide is too high. Approximately 295,000 women died during and following childbirth in 2017. Most of these deaths (94%) occurred in locations where women have few resources. But no matter what corner of the globe you live in, most of these deaths could have been prevented.
If we don’t do more, mothers, daughters and granddaughters will continue to lose their lives. And their loss will impact many.